Daniel J. Lippis, CVP, JAPAC at Edwards Lifesciences Corp (EW), sold 2,300 shares at $85.60 ($197K) on 2024-05-07, disclosed to the SEC on 2024-05-09.
Scheduled sale ($197k) by CVP, JAPAC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.09 | 586 | $50K | 25.4% |
| 2 | $85.60 | 857 | $73K | 37.3% |
| 3 | $85.60 | 857 | $73K | 37.3% |
| Total | $85.47 avg | 2,300 | $197K | 100% |
| Filing → |
| EW | SELL | 2026-08-11 | $57K | — | Filing → |
| EW | SELL | 2026-07-10 | $57K | — | Filing → |
| EW | SELL | 2026-06-30 | $57K | — | Filing → |